Biological markers of myocardial necrosis (Q44509338)

3 December 2017

1 reference

title

Biological markers of myocardial necrosis (English)

1 reference

3 December 2017

Miguel Santaló Bel

1

1 reference

3 December 2017

Josep Guindo Soldevila

series ordinal

2

1 reference

3 December 2017

Jordi Ordóñez Llanos

series ordinal

3

1 reference

3 December 2017

language of work or name

Spanish

0 references

publication date

1 July 2003

1 reference

Revista Española de Cardiología

3 December 2017

published in

1 reference

3 December 2017

volume

56

1 reference

3 December 2017

issue

7

1 reference

3 December 2017

page(s)

703-720

1 reference

Missed diagnoses of acute cardiac ischemia in the emergency department.

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Prognostic Value of the Admission Electrocardiogram in Acute Coronary Syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Pregnancy-associated plasma protein A as a marker of acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

1 reference

7 January 2021

Biochemical markers of myocardial injury. Is MB creatine kinase the choice for the 1990s?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

The diagnosis of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

The creatine kinase system in normal and diseased human myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Serum creatine kinase isoenzymes: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Abnormal cardiac enzyme responses after strenuous exercise: alternative diagnostic aids.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Several Conditions Causing Elevation of Serum CK-MB and CK-BB

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Early detection of acute myocardial infarction in patients presenting with chest pain and nondiagnostic ECGs: serial CK-MB sampling in the emergency department

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Early detection of acute myocardial infarction by measurement of mass concentration of creatine kinase-MB

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Early diagnosis of acute myocardial infarction by CK-MB mass measurements

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

The role of single ECG, creatinine kinase, and CKMB in diagnosing patients with acute chest pain

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Failure of new biochemical markers to exclude acute myocardial infarction at admission

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Use of a rapid assay of subforms of creatine kinase MB to diagnose or rule out acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Diagnostic marker cooperative study for the diagnosis of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

The use of myoglobin/carbonic anhydrase III ratio as a marker for myocardial damage in patients with renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Serum myoglobin determinations in the assessment of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

The value of serum myoglobin determinations in the early diagnosis of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Myoglobin as an early indicator of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Early detection of acute myocardial infarction: additional diagnostic information from serum concentrations of myoglobin in patients without ST elevation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Early diagnosis of acute myocardial infarction in patients without ST-segment elevation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Strategies for the early diagnosis of acute myocardial infarction using biochemical markers

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Measurement of cardiac troponins

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Release kinetics of serum cardiac troponin I in ischemic myocardial injury

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Diagnostic performance and prognostic value of serum troponin T in suspected acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Myocardial infarction redefined—A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Cardiac troponin I. A marker with high specificity for cardiac injury

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

New diagnostic criteria for myocardial infarction: order in chaos

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Guidelines for the diagnosis and management of unstable angina and non-Q-wave myocardial infarction: proposed revisions. International Cardiology Forum

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Measurement of cardiac troponin T is an effective method for predicting complications among emergency department patients with chest pain

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Value of serial myoglobin levels in the early diagnosis of patients admitted for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Value of myoglobin, troponin T, and CK-MBmass in ruling out an acute myocardial infarction in the emergency room

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Diagnosis of acute myocardial infarction from sequential enzyme measurements obtained within 12 hours of admission to hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Evaluation of a new rapid quantitative immunoassay for serum myoglobin versus CK-MB for ruling out acute myocardial infarction in the emergency department

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Combined cardiac marker approach with adjunct two-dimensional echocardiography to diagnose acute myocardial infarction in the emergency department

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Acute myocardial infarction in chest pain patients with nondiagnostic ECGs: serial CK-MB sampling in the emergency department. The Emergency Medicine Cardiac Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Use of rapid serial sampling of creatine kinase MB for very early detection of myocardial infarction in patients with acute chest pain

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation. PURSUIT Steering Committee. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppressio

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Effects of tirofiban plus heparin versus heparin alone on troponin I levels in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Ninety-minute accelerated critical pathway for chest pain evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Comparison of cardiac troponin T versus creatine kinase-MB for risk stratification in a chest pain evaluation unit

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Use of the Acute Cardiac Ischemia Time-Insensitive Predictive Instrument (ACI-TIPI) To Assist with Triage of Patients with Chest Pain or Other Symptoms Suggestive of Acute Cardiac Ischemia: A Multicenter, Controlled Clinical Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Risk stratification in unstable coronary artery disease. Additive value of troponin T determinations and pre-discharge exercise tests. FRISK Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Risk stratifying acute coronary syndromes: gradient of risk and benefit

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

The Prognostic Value of Serum Troponin T in Unstable Angina

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Troponin T as a marker of ischemic myocardial injury

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Independent prognostic value of serum creatine kinase isoenzyme MB mass, cardiac troponin T and myosin light chain levels in suspected acute myocardial infarction. Analysis of 28 months of follow-up in 196 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Early identification of cardiac events with serum troponin T in patients with unstable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Prognostic significance of admission troponin T concentrations in patients with myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Comparison of the prognostic value of C-Reactive protein and troponin I in patients with unstable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Prognostic role of troponin T versus troponin I in unstable angina pectoris for cardiac events with meta-analysis comparing published studies

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Key factors in the identification of the high-risk patient with unstable coronary artery disease: clinical findings, resting 12-lead electrocardiogram, and continuous electrocardiographic monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Relative contributions of a single-admission 12-lead electrocardiogram and early 24-hour continuous electrocardiographic monitoring for early risk stratification in patients with unstable coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease. TRIM Study Group. Thrombin Inhibition in Myocardial ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Evaluation of the emergency department chest pain patient

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. PRISM Study Investigators. Platelet Receptor Inhibition in Ischemic Syndrome Management

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin t-positive status: the paragon-B troponin T substudy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina. The PARAGON Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute coronary syndrome events i

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976942-5

7 January 2021

10.1016/S0300-8932(03)76942-5

Identifiers

DOI

1 reference

3 December 2017

1 reference